Two female nonsmoker Buerger's disease cases with anticardiolipin autoantibodies and a poor prognosis

International Heart Journal

Volumn 46, Issue 3, 2005, Pages 563-569

  Heper, Gulumser ^a,c   Kose, Sedat ^b   Akkoc, Ozkan ^a   Amasyali, Basri ^b   Kilic, Ayhan ^b  

^a Social Security Hospital   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

Anticardiolipin autoantibodies; Buerger's disease; Thromboangiitis obliterans

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CARDIOLIPIN ANTIBODY; ILOPROST; PROSTANOID; AUTOANTIBODY;

ADULT; ANAMNESIS; ANTIBODY DETECTION; ARTERIOGRAPHY; ARTICLE; BUERGER DISEASE; CASE REPORT; CLINICAL FEATURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FINGER AMPUTATION; HEPARINIZATION; HUMAN; HYPERTENSION; KIDNEY ARTERIOGRAPHY; LEG AMPUTATION; PAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; STENT; SYMPATHECTOMY; TOE GANGRENE; TREATMENT FAILURE; TREATMENT OUTCOME; ULCER; ANGIOGRAPHY; BLOOD; IMMUNOLOGY; MIDDLE AGED; RADIOGRAPHY; RENAL ARTERY; ULNAR ARTERY;

ADULT; ANGIOGRAPHY; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; RENAL ARTERY; THROMBOANGIITIS OBLITERANS; ULNAR ARTERY;

EID: 26044459660     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.46.563     Document Type: Article

References (13)

1. Nunez GA, Lopez CL, Rico ZL, Molins OA, Gomez OJ, Arribas A. Thromboangiitis obliterans (Buergees disease) with intestinal involvement - a case report. Angiology 1998; 49: 489-92.
2. Swigris JJ, Olin JW, Mekhail NA. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease). J Vasc Surg 1999; 29: 928-35.
3. Sasaki S, Sakuma M, Kunihara T, Yasuda K. Current trends in thromboangiitis obliterans (Buerger's disease) in women. Am J Surg 1999; 177: 316-20.
4. Papa M, Bass A, Adar R, et al. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex. Surgery 1992; 11: 527-31.
5. Mills JL. Buerger's disease. Current Status. Vasc Med Rev 1994; 5: 139-50.
6. Olin JW, Young JR, Graor RA, et al. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation 1990; 82 (5 Suppl): IV3-8.
7. Nielubowicz J, Rosnowski A, Pruszynski B, Przetakiewicz Z, Potemkowski A. Natural history of Buerger's disease. J Cardiovasc Surg (Torino) 1980; 21: 529-40.
8. Mills JL, Porter JM. Buerger's disease (thromboangiitis obliterans). Ann Vasc Surg 1991; 5: 570-2. (Review)
9. Buerger L. The Circulatory Disturbances of the Extremities Including Gangrene, Vasomotor and Trophic Disorders. Philadelphia, W.B. Saunders, Company, 1924.
10. Kobayashi M, Ito M, Nakagawa A, Nishikimi N, Nimura Y. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans). J Vasc Surg 1999; 29: 451-8.
11. Maslowski L, McBane R, Alexewicz P, Wysokinski WE. Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med 2002; 7: 259-64.
12. Merrill JT. Diagnosis of the antiphospholipid syndrome: how far to go? Curr Rheumatol Rep 2004; 6: 469-72.
13. Segelmark M, Westman K, Wieslander J. How and why should we detect ANCA? Clin Exp Rheumatol 2000; 18: 629-35.